Other Species / Isoforms
  YY1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y8-p
MASGDTLyIATDGSE
Upstream
1 0
Putative in vivo kinases:
  • LYN (human)
YY1 (human) MASGDTLyIATDGSE Y8-p
YY1 (mouse) MASGDTLYIATDGSE Y8
YY1 (rat) MASGDTLYIATDGSE Y8
T30
LHEIEVETIPVETIE
1 0
YY1 (human) LHEIEVETIPVETIE T30
YY1 (mouse) LHEIEVEtIPVETIE T30-p
YY1 (rat) LHEIEVETIPVETIE T30
T39-p
PVETIETtVVGEEEE
Upstream
1 0
Kinase, in vitro:
  • PLK1 (human)
Putative in vivo kinases:
  • PLK1 (human)
Treatment
  • Cyclapolin9
YY1 (human) PVETIETtVVGEEEE T39-p
YY1 (mouse) PVETIETTVVGEEEE T39
YY1 (rat) PVETIETTVVGEEED T39
S118-p
EVVGGDDsDGLRAED
Upstream
Downstream
2 32
Effects on Modified Protein
  • protein stabilization
Kinase, in vitro:
  • CK2A1 (human)
Putative in vivo kinases:
  • CK2A1 (human)
Treatment
  • DMAT
  • siRNA
  • TBCA
YY1 (human) EVVGGDDsDGLRAED S118-p
YY1 (mouse) EVVGGDDsDGLRAED S120-p
YY1 (rat) EVVGGDDsDGLRAED S117-p
K158-sm
VTVAAAGkSGGGGSs
0 1
YY1 (human) VTVAAAGkSGGGGSs K158-sm
YY1 (mouse) VTVAAAGKSGGGASS K160
YY1 (rat) VTVAAAGKSGGGSSS K157
S165-p
kSGGGGSsSSGGGrV
0 1
YY1 (human) kSGGGGSsSSGGGrV S165-p
YY1 (mouse) AGKSGGGASSGGGRV A165
YY1 (rat) AGKSGGGSSSGGGRV S162
R171-m1
SsSSGGGrVkkGGGK
0 2
YY1 (human) SsSSGGGrVkkGGGK R171-m1
YY1 (mouse) GASSGGGRVKKGGGK R171
YY1 (rat) GSSSGGGRVKKGGGK R168
K173-ub
SSGGGrVkkGGGKKs
0 1
YY1 (human) SSGGGrVkkGGGKKs K173-ub
YY1 (mouse) SSGGGRVKKGGGKKS K173
YY1 (rat) SSGGGRVKKGGGKKS K170
K174-ac
SGGGrVkkGGGKKsG
0 1
YY1 (human) SGGGrVkkGGGKKsG K174-ac
YY1 (mouse) SGGGRVKKGGGKKSG K174
YY1 (rat) SGGGRVKKGGGKKSG K171
S180-p
kkGGGKKsGKksyLs
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
YY1 (human) kkGGGKKsGKksyLs S180-p
YY1 (mouse) KKGGGKKSGKksYLG S180
YY1 (rat) KKGGGKKSGKKSYLG S177
K183-ub
GGKKsGKksyLsGGA
0 4
YY1 (human) GGKKsGKksyLsGGA K183-ub
YY1 (mouse) GGKKSGKksYLGGGA K183-ub
YY1 (rat) GGKKSGKKSYLGSGA K180
K183-sm
GGKKsGKksyLsGGA
0 2
YY1 (human) GGKKsGKksyLsGGA K183-sm
YY1 (mouse) GGKKSGKKsYLGGGA K183
YY1 (rat) GGKKSGKKSYLGSGA K180
K183-m1
GGKKsGKksyLsGGA
0 1
YY1 (human) GGKKsGKksyLsGGA K183-m1
YY1 (mouse) GGKKSGKKsYLGGGA K183
YY1 (rat) GGKKSGKKSYLGSGA K180
S184-p
GKKsGKksyLsGGAG
Upstream
Downstream
2 3
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • AurB (human)
Phosphatases, in vitro:
  • PPP1CA (human)
Putative in vivo kinases:
  • AurB (human)
Treatment
  • nocodazole
YY1 (human) GKKsGKksyLsGGAG S184-p
YY1 (mouse) GKKSGKksYLGGGAG S184-p
YY1 (rat) GKKSGKKSYLGSGAG S181
Y185-p
KKsGKksyLsGGAGA
0 1
YY1 (human) KKsGKksyLsGGAGA Y185-p
YY1 (mouse) KKSGKksYLGGGAGA Y185
YY1 (rat) KKSGKKSYLGSGAGA Y182
S187-p
sGKksyLsGGAGAAG
0 7
YY1 (human) sGKksyLsGGAGAAG S187-p
YY1 (mouse) SGKksYLGGGAGAAG G187
YY1 (rat) SGKKSYLGSGAGAAG G184
K203-ac
GGADPGNkkWEQkQV
0 5
YY1 (human) GGADPGNkkWEQkQV K203-ac
YY1 (mouse) GGADPGNKKWEQKQV K203
YY1 (rat) GGADPGNKKWEQKQV K200
K203-ub
GGADPGNkkWEQkQV
0 2
YY1 (human) GGADPGNkkWEQkQV K203-ub
YY1 (mouse) GGADPGNKKWEQKQV K203
YY1 (rat) GGADPGNKKWEQKQV K200
K203-sm
GGADPGNkkWEQkQV
1 0
YY1 (human) GGADPGNkkWEQkQV K203-sm
YY1 (mouse) GGADPGNKKWEQKQV K203
YY1 (rat) GGADPGNKKWEQKQV K200
K204-ac
GADPGNkkWEQkQVQ
0 1
YY1 (human) GADPGNkkWEQkQVQ K204-ac
YY1 (mouse) GADPGNKKWEQKQVQ K204
YY1 (rat) GADPGNKKWEQKQVQ K201
K208-ub
GNkkWEQkQVQIKTL
0 3
YY1 (human) GNkkWEQkQVQIKTL K208-ub
YY1 (mouse) GNKKWEQKQVQIKTL K208
YY1 (rat) GNKKWEQKQVQIKTL K205
S225-p
EFSVTMWssDEKKDI
0 1
YY1 (human) EFSVTMWssDEKKDI S225-p
YY1 (mouse) EFSVTMWSSDEKKDI S225
YY1 (rat) EFSVTMWSSDEKKDI S222
S226-p
FSVTMWssDEKKDID
0 1
YY1 (human) FSVTMWssDEKKDID S226-p
YY1 (mouse) FSVTMWSSDEKKDID S226
YY1 (rat) FSVTMWSSDEKKDID S223
S247-p
EQIIGENsPPDySEy
Upstream
2 36
Treatment
  • anti-CD3
YY1 (human) EQIIGENsPPDySEy S247-p
YY1 (mouse) EQIIGENsPPDYsEY S247-p
YY1 (rat) EQIIGENsPPDYSEY S244-p
Y251-p
GENsPPDySEyMTGk
0 2
YY1 (human) GENsPPDySEyMTGk Y251-p
YY1 (mouse) GENsPPDYsEYMTGK Y251
YY1 (rat) GENsPPDYSEYMTGK Y248
S252
ENsPPDySEyMTGkK
0 1
YY1 (human) ENsPPDySEyMTGkK S252
YY1 (mouse) ENsPPDYsEYMTGKK S252-p
YY1 (rat) ENsPPDYSEYMTGKK S249
Y254-p
sPPDySEyMTGkKLP
Upstream
Downstream
2 1
Effects on Biological Processes:
  • transcription, inhibited
Kinase, in vitro:
  • Abl (human)
Putative in vivo kinases:
  • Abl (human)
  • LYN (human)
YY1 (human) sPPDySEyMTGkKLP Y254-p
YY1 (mouse) sPPDYsEYMTGKKLP Y254
YY1 (rat) sPPDYSEYMTGKKLP Y251
K258-ac
ySEyMTGkKLPPGGI
0 1
YY1 (human) ySEyMTGkKLPPGGI K258-ac
YY1 (mouse) YsEYMTGKKLPPGGI K258
YY1 (rat) YSEYMTGKKLPPGGI K255
K258-ub
ySEyMTGkKLPPGGI
0 2
YY1 (human) ySEyMTGkKLPPGGI K258-ub
YY1 (mouse) YsEYMTGKKLPPGGI K258
YY1 (rat) YSEYMTGKKLPPGGI K255
K286-sm
FARMKPRkIkEDDAP
0 1
YY1 (human) FARMKPRkIkEDDAP K286-sm
YY1 (mouse) FARMKPRKIKEDDAP K286
YY1 (rat) FARMKPRKIKEDDAP K283
K288-ub
RMKPRkIkEDDAPRT
0 1
YY1 (human) RMKPRkIkEDDAPRT K288-ub
YY1 (mouse) RMKPRKIKEDDAPRT K288
YY1 (rat) RMKPRKIKEDDAPRT K285
K288-sm
RMKPRkIkEDDAPRT
1 2
YY1 (human) RMKPRkIkEDDAPRT K288-sm
YY1 (mouse) RMKPRKIKEDDAPRT K288
YY1 (rat) RMKPRKIKEDDAPRT K285
K301-ub
RTIACPHkGCTkMFr
0 1
YY1 (human) RTIACPHkGCTkMFr K301-ub
YY1 (mouse) RTIACPHKGCTKMFR K301
YY1 (rat) RTIACPHKGCTKMFR K298
K301-m1
RTIACPHkGCTkMFr
0 1
YY1 (human) RTIACPHkGCTkMFr K301-m1
YY1 (mouse) RTIACPHKGCTKMFR K301
YY1 (rat) RTIACPHKGCTKMFR K298
K305-ub
CPHkGCTkMFrDNsA
0 2
YY1 (human) CPHkGCTkMFrDNsA K305-ub
YY1 (mouse) CPHKGCTKMFRDNsA K305
YY1 (rat) CPHKGCTKMFRDNSA K302
K305-m1
CPHkGCTkMFrDNsA
0 1
YY1 (human) CPHkGCTkMFrDNsA K305-m1
YY1 (mouse) CPHKGCTKMFRDNsA K305
YY1 (rat) CPHKGCTKMFRDNSA K302
R308-m1
kGCTkMFrDNsAMRk
0 1
YY1 (human) kGCTkMFrDNsAMRk R308-m1
YY1 (mouse) KGCTKMFRDNsAMRK R308
YY1 (rat) KGCTKMFRDNSAMRK R305
S311-p
TkMFrDNsAMRkHLH
0 2
YY1 (human) TkMFrDNsAMRkHLH S311-p
YY1 (mouse) TKMFRDNsAMRKHLH S311-p
YY1 (rat) TKMFRDNSAMRKHLH S308
K315-ub
rDNsAMRkHLHTHGP
0 1
YY1 (human) rDNsAMRkHLHTHGP K315-ub
YY1 (mouse) RDNsAMRKHLHTHGP K315
YY1 (rat) RDNSAMRKHLHTHGP K312
K315-m1
rDNsAMRkHLHTHGP
0 1
YY1 (human) rDNsAMRkHLHTHGP K315-m1
YY1 (mouse) RDNsAMRKHLHTHGP K315
YY1 (rat) RDNSAMRKHLHTHGP K312
K332-ub
HVCAECGkAFVESSk
0 2
YY1 (human) HVCAECGkAFVESSk K332-ub
YY1 (mouse) HVCAECGKAFVESSK K332
YY1 (rat) HVCAECGKAFVESSk K329
K339-ac
kAFVESSkLKRHQLV
0 4
YY1 (human) kAFVESSkLKRHQLV K339-ac
YY1 (mouse) KAFVESSKLKRHQLV K339
YY1 (rat) KAFVESSkLKRHQLV K336-ac
T348-p
KRHQLVHtGEkPFQC
Upstream
Downstream
1 16
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Treatment
  • nocodazole
YY1 (human) KRHQLVHtGEkPFQC T348-p
YY1 (mouse) KRHQLVHtGEKPFQC T348-p
YY1 (rat) KRHQLVHTGEKPFQC T345
K351-ac
QLVHtGEkPFQCTFE
0 6
YY1 (human) QLVHtGEkPFQCTFE K351-ac
YY1 (mouse) QLVHtGEKPFQCTFE K351
YY1 (rat) QLVHTGEKPFQCTFE K348
S365-p
EGCGKRFsLDFNLRT
Upstream
Downstream
2 8
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • AurA (human)
Putative in vivo kinases:
  • AurA (human)
Treatment
  • nocodazole
  • taxol
  • VX-680
YY1 (human) EGCGKRFsLDFNLRT S365-p
YY1 (mouse) EGCGKRFsLDFNLRT S365-p
YY1 (rat) EGCGKRFSLDFNLRT S362
T378-p
RTHVRIHtGDrPyVC
Upstream
Downstream
1 49
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Treatment
  • nocodazole
YY1 (human) RTHVRIHtGDrPyVC T378-p
YY1 (mouse) RTHVRIHtGDRPYVC T378-p
YY1 (rat) RTHVRIHTGDRPYVC T375
R381-m1
VRIHtGDrPyVCPFD
0 1
YY1 (human) VRIHtGDrPyVCPFD R381-m1
YY1 (mouse) VRIHtGDRPYVCPFD R381
YY1 (rat) VRIHTGDRPYVCPFD R378
Y383-p
IHtGDrPyVCPFDGC
Upstream
Downstream
1 0
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • transcription, inhibited
Kinase, in vitro:
  • LYN (human)
Putative in vivo kinases:
  • LYN (human)
YY1 (human) IHtGDrPyVCPFDGC Y383-p
YY1 (mouse) IHtGDRPYVCPFDGC Y383
YY1 (rat) IHTGDRPYVCPFDGC Y380
S397
CNKKFAQSTNLkSHI
0 1
YY1 (human) CNKKFAQSTNLkSHI S397
YY1 (mouse) CNKKFAQstNLKsHI S397-p
YY1 (rat) CNKKFAQSTNLKSHI S394
T398
NKKFAQSTNLkSHIL
0 1
YY1 (human) NKKFAQSTNLkSHIL T398
YY1 (mouse) NKKFAQstNLKsHIL T398-p
YY1 (rat) NKKFAQSTNLKSHIL T395
K401-ub
FAQSTNLkSHILTHA
0 4
YY1 (human) FAQSTNLkSHILTHA K401-ub
YY1 (mouse) FAQstNLKsHILTHA K401
YY1 (rat) FAQSTNLKSHILTHA K398
K401-sm
FAQSTNLkSHILTHA
0 1
YY1 (human) FAQSTNLkSHILTHA K401-sm
YY1 (mouse) FAQstNLKsHILTHA K401
YY1 (rat) FAQSTNLKSHILTHA K398
S402
AQSTNLkSHILTHAk
0 1
YY1 (human) AQSTNLkSHILTHAk S402
YY1 (mouse) AQstNLKsHILTHAK S402-p
YY1 (rat) AQSTNLKSHILTHAK S399
K409-ub
SHILTHAkAKNNQ__
0 4
YY1 (human) SHILTHAkAKNNQ__ K409-ub
YY1 (mouse) sHILTHAKAKNNQ__ K409
YY1 (rat) SHILTHAKAKNNQ__ K406
K409-sm
SHILTHAkAKNNQ__
0 1
YY1 (human) SHILTHAkAKNNQ__ K409-sm
YY1 (mouse) sHILTHAKAKNNQ__ K409
YY1 (rat) SHILTHAKAKNNQ__ K406